Records containing: Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-10-04Prevalence Analysis of Ocular Disorders in Patients on Treatment for Symptomatic Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-09-28A Two Part Phase 1 Multicenter Open-label Study of DKN-01 Given Intravenously. Part A: Dose-Escalation in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: Expansion Cohort in Patients With Relapsed / Refractory Non-Small Cell Lung Cancer (NSCLC)
-
CLINICAL_TRIALS study record update · 2016-09-27A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
-
CLINICAL_TRIALS study record update · 2016-09-26A Phase I Study of JNJ-54761414 (Daratumumab) in Japanese Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-09-23A Phase I/II Trial of Cyclophosphamide, Carfilzomib, Thalidomide and Dexamethasone (CYCLONE) in Patients With Newly Diagnosed Active Multiple Myeloma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-09-20Phase II Study of Intensive "TOTAL THERAPY" for Untreated or Minimally Treated Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-09-20A Randomized Placebo-controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-09-08A Randomized Study of 4 vs. 8 Cycles of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients
-
CLINICAL_TRIALS study record update · 2016-09-01A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-24A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-24Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
-
CLINICAL_TRIALS study record update · 2016-08-24An Open, Multicentric Phase II Trial to Evaluate the Efficacy and Safety of Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-24Phase II Trial of Bortezomib, Low Dose Dexamethasone, and Doxorubicin With Acetyl-L-Carnitine for Neuroprotection in Patients With Previously Treated Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-22Chemotherapy and Anti-angiogenic Agents- Induced Thrombosis in Cancer.
-
CLINICAL_TRIALS study record update · 2016-08-19A Phase 1 Dose Escalation Study of Infusion of ex Vivo cd3/cd28 Costimulated Umbilical Cord Blood-derived t Cells in Adults Undergoing Transplantation for Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-08-17Institut Paoli Calmettes Multiple Myeloma Database
-
CLINICAL_TRIALS study record update · 2016-08-11Clinical and Pharmacodynamic Comparison of Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-10Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-04A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy vs Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN #0102)
-
CLINICAL_TRIALS study record update · 2016-08-03Phase I Study of Malignancies That Express NY-ESO-1 With T Cell Receptor-transduced T Cells Targeting NY-ESO-1
-
CLINICAL_TRIALS study record update · 2016-07-26Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-07-25Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis
-
CLINICAL_TRIALS study record update · 2016-07-22A Phase II Trial of TBL 12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma
-
CLINICAL_TRIALS study record update · 2016-07-22COMPARE: Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-07-22A Phase II Study of Umbilical Cord Blood Transplantation Following Myeloablative or Reduced-Intensity Conditioning